Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Pharma
Pharma industry reaches 'landmark' drug spending deal with UK
The U.K. government has agreed to increase the allowed annual revenue growth rate for branded drugs from 2% in 2024 to 4% by 2027.
Angus Liu
Nov 20, 2023 11:00am
Teva taps Royalty to bankroll long-acting schizophrenia drug
Nov 13, 2023 11:40am
Strides African unit nabs WHO nod to produce malaria treatment
Nov 8, 2023 10:10am
Forge blazes into collaboration to bolster AAV gene therapies
Oct 12, 2023 9:25am
BMS buys Mirati for up to $5.8B as I-O giant branches out
Oct 9, 2023 3:29am
After short FTC fight, Amgen wraps up $27.8B Horizon buyout
Oct 6, 2023 10:46am
